Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 313

Trial Status

Completed12
Terminated5

Role Distribution

Other Roles17

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (17)

Showing 17 of 17 trials

NCT00286429Phase 3StudyDirector

Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.

Diabetes Mellitus
Completed
NCT00286442Phase 3StudyDirector

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Diabetes Mellitus
Completed
NCT00286455Phase 3StudyDirector

Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Diabetes Mellitus
Completed
NCT00286468Phase 3StudyDirector

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Diabetes Mellitus
Completed
NCT00286494Phase 3StudyDirector

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Completed
NCT00306384Phase 3StudyDirector

Long-term Safety of Alogliptin in Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus
Completed
NCT00328627Phase 3StudyDirector

Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.

Type 2 Diabetes Mellitus
Completed
NCT00432276Phase 3StudyDirector

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Completed
NCT00707993Phase 3StudyDirector

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Diabetes Mellitus
Completed
NCT00755846Phase 2StudyDirector

Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.

Diabetes Mellitus
Completed
NCT00760344Phase 2StudyDirector

Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Completed
NCT00760864Phase 2StudyDirector

Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis

Arthritis, Rheumatoid
Completed
NCT00762112Phase 3StudyDirector

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Terminated
NCT00762190Phase 3StudyDirector

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Terminated
NCT00762684Phase 3StudyDirector

Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Terminated
NCT00762957Phase 3StudyDirector

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus
Terminated
NCT00763347Phase 2StudyDirector

Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus
Terminated

All 17 trials loaded